| Literature DB >> 28544176 |
Jing Zhao1,2, Xiangzhu Zhu1,2, Martha J Shrubsole1,2,3, Reid M Ness3,4, Elizabeth A Hibler1, Qiuyin Cai1, Jirong Long1, Zhi Chen1, Ming Jiang1,5, Edmond K Kabagambe1, Bing Zhang4,6, Lifang Hou7, Walter E Smalley2,4, Todd L Edwards1,2, Edward L Giovannucci8, Wei Zheng1,2,3, Qi Dai1,2,3.
Abstract
The SLC8A1 (solute carrier family 8, member 1) gene, encoding Na+ /Ca2+ exchanger, is essential in regulating calcium reabsorption and homeostasis. Calcium homeostasis plays a key role in cell proliferation and apoptosis. We hypothesized that polymorphisms in five calcium-regulating genes (SLC8A1, ATP2B1, CALB1, CALB2, and CABP1) interact with calcium intake in relation to the risk of colorectal neoplasia. A two-phase (discovery and replication) study was conducted within the Tennessee Colorectal Polyp Study, including a total of 1275 cases and 2811 controls. In Phase I, we identified six out of 135 SNPs that significantly interacted with calcium intake in relation to adenoma risk. In Phase II, the calcium intake by rs4952490 (SLC8A1) interaction was replicated (Pinteraction = 0.048). We found an inverse association between calcium intake (1000-2000 mg/day) and colorectal adenomas, particularly for multiple/advanced adenomas, among the G-allele carriers but not among homozygous carriers of the common variant (A) in rs4952490. In the joint analysis of SLC8A1, KCNJ1, and SLC12A1 SNPs, carriers of variant alleles in at least two genes and with calcium intake above the DRI (1000 mg/day) were approximately 30-57% less likely to have adenomas than those whose calcium intake was below the DRI. The association was stronger for multiple/advanced adenomas. No association was found among those who did not carry any variant alleles in these genes when calcium intake was below 2500 mg/day. These findings, if confirmed, may provide a new avenue for the personalized prevention of colorectal adenoma and cancer.Entities:
Keywords: KCNJ1; SLC12A1; SLC8A1; colorectal neoplasia; gene-calcium interaction
Mesh:
Substances:
Year: 2017 PMID: 28544176 PMCID: PMC5609815 DOI: 10.1002/mc.22678
Source DB: PubMed Journal: Mol Carcinog ISSN: 0899-1987 Impact factor: 4.784